1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling
    Journal Article

    Oh, G.; Wang, A.; Wang, L.; Li, J.; Werba, G.; Weissinger, D.; Zhao, E.; Dhara, S.; Hernandez, R.E.; Ackermann, A.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Association of polycystic ovary syndrome with pancreatic cancer—Reply
    Correspondence

    Peeri, N. C.; Du, M.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Association between geriatric impairments and quality of life in older adults with lymphoma on oral targeted therapies: A one‐year prospective study
    Meeting Abstract

    Torka, P.; Akhtar, O.; Kaijar, T.; Wang, K.; Attwood, K.; Carozza, D.; Bouchard, E.; Ghione, P.; Cortese, M.; Wildes, T.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Primary hepatic lymphoma: Role of low-dose radiotherapy and paired literature review
    Meeting Abstract

    Ma, J.; Daou, R.; Eid, J. Bou; Lee, J.; Fregonese, B.; El‐Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Drug‐resistance mutations in BTK occur in distinct enzymatic classes and are overcome by BTK degradation
    Meeting Abstract

    Montoya, S.; Bourcie, J.; Sondhi, A.; Jahn, J.; Alencar, A.; Abdel-Wahab, O.; Taylor, J.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiation in a new era of multiple myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response
    Meeting Abstract

    Dreyfuss, A. D.; Fregonese, B.; Ma, J.; Reith, S.; Cederquist, G.; Hubbeling, H.; Tringale, K. R.; Wijetunga, N. A.; Usmani, S.; Hajj, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • The prognostic value of progressing within 24 months of frontline chemoimmunotherapy (POD24) in relapsed/refractory (R/R) follicular lymphoma (FL)—a SCHOLAR‐5 analysis
    Meeting Abstract

    Patel, A. R.; Limbrick‐Oldfield, E. H.; Kanters, S.; Ray, M. D.; Best, T.; Ghione, P.; Neelapu, S. S.; Gribben, J. G.; Beygi, S.; Bobillo, S.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A single‐center experience of low‐dose radiotherapy for primary extranodal marginal zone lymphoma of bronchus‐associated lymphoid tissue (BALT)
    Meeting Abstract

    Freret, M. E.; Tringale, K. R.; Imber, B. S.; Joffe, E.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save